8-Chloro-3-methoxy-1,5-naphthyridine, 95.0%, 100mg

2-(4-Chloromethyl-piperidin-1-yl)-5-fluoro-pyrimidine, 95.0%, 250mg

3-Fluoro-4-methylthiophenol, 97.0%, 1g

4-(4-(Aminomethyl)-3-methylphenyl)-N-(1-methyl-1H-pyrazol-4-yl)pyrimidin-2-amine hydrochloride, 97%, 100mg

GC-Kapillarsäule ROTI®Cap-5 MS Ultra, L 50 m, Ø-Innen 0,20 mm, Filmd. 0,35 µm, 1 Stück

3,4'-Diaminodiphenylmethane>98.0%(GC)(T)1g

(Z)-6-fluoro-3-((1-methyl-1H-1,2,4-triazol-5-yl)methylene)-4-nitroisobenzofuran-1(3H)-one, 98%, 100mg

3-METHYL-2-(PYRROLIDIN-2-YL)PYRIDINE HCL, 96.0%, 250mg

(3R,4S)-1-(tert-Butoxycarbonyl)-4-(pyridin-4-yl)pyrrolidine-3-carboxylic acid, 95.0%, 1g

2,3-Dihydro-1,4-benzodioxin-6-ylmethanamine hydrochloride, 95+%, 250mg

3-Cyano-4-methylpyridine>98.0%(GC)1g

3-(3-Bromo-phenyl)-5-chloro-[1,2,4]thiadiazole, 95.0%, 1g

2-Amino-2-(3-methoxyphenyl)acetic acid, 95.0%, 250mg